🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 11 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/10/2014 | 51,74 | 51,78 | 51,45 | 51,57 | +0,06% | 0,65% | 12.643.177 |
| 17/10/2014 | 51,38 | 52,13 | 51,08 | 51,55 | +1,10% | 2,04% | 20.664.569 |
| 16/10/2014 | 51,54 | 51,61 | 50,09 | 50,98 | -2,38% | 2,96% | 22.905.298 |
| 15/10/2014 | 52,83 | 53,31 | 51,80 | 52,22 | -2,84% | 2,85% | 19.687.518 |
| 14/10/2014 | 53,98 | 54,34 | 53,18 | 53,75 | +0,34% | 2,16% | 11.460.718 |
| 13/10/2014 | 55,87 | 55,87 | 53,42 | 53,57 | -4,30% | 4,39% | 15.518.470 |
| 10/10/2014 | 56,59 | 57,18 | 55,97 | 55,97 | -0,93% | 2,12% | 11.826.890 |
| 09/10/2014 | 57,25 | 57,74 | 56,40 | 56,50 | -1,61% | 2,33% | 9.008.398 |
| 08/10/2014 | 55,97 | 57,47 | 55,89 | 57,42 | +2,94% | 2,83% | 12.909.474 |
| 07/10/2014 | 56,60 | 56,68 | 55,77 | 55,78 | -1,88% | 1,60% | 9.977.065 |
| 06/10/2014 | 57,41 | 57,49 | 56,58 | 56,85 | -0,53% | 1,58% | 7.456.101 |
| 03/10/2014 | 56,46 | 57,35 | 56,46 | 57,16 | +1,78% | 1,57% | 9.056.606 |
| 02/10/2014 | 56,09 | 56,36 | 55,62 | 56,15 | +0,24% | 1,31% | 8.499.070 |
| 01/10/2014 | 56,38 | 56,51 | 55,82 | 56,02 | -0,96% | 1,22% | 9.525.167 |
| 30/09/2014 | 56,68 | 57,23 | 56,54 | 56,56 | -0,22% | 1,23% | 9.691.170 |
| 29/09/2014 | 56,33 | 56,98 | 56,12 | 56,69 | +0,03% | 1,54% | 9.137.722 |
| 26/09/2014 | 56,98 | 57,05 | 55,87 | 56,67 | -0,42% | 2,08% | 11.303.938 |
| 25/09/2014 | 57,52 | 57,73 | 56,90 | 56,91 | -1,19% | 1,44% | 9.109.006 |
| 24/09/2014 | 57,55 | 57,77 | 57,47 | 57,60 | +0,13% | 0,51% | 12.015.949 |
| 23/09/2014 | 57,40 | 57,95 | 56,96 | 57,52 | -0,50% | 1,73% | 8.396.681 |
| 22/09/2014 | 57,61 | 58,19 | 57,50 | 57,81 | +0,15% | 1,19% | 9.767.884 |
| 19/09/2014 | 57,97 | 58,10 | 57,72 | 57,72 | +0,30% | 0,66% | 15.175.774 |
| 18/09/2014 | 57,38 | 57,58 | 57,08 | 57,55 | +0,72% | 0,86% | 8.388.297 |
| 17/09/2014 | 56,80 | 57,26 | 56,56 | 57,14 | -0,18% | 1,23% | 10.764.218 |
| 16/09/2014 | 56,78 | 57,31 | 56,56 | 57,24 | +0,79% | 1,31% | 9.479.579 |
| 15/09/2014 | 56,92 | 57,24 | 56,77 | 56,79 | -0,05% | 0,82% | 8.110.367 |
| 12/09/2014 | 57,14 | 57,38 | 56,55 | 56,82 | -0,92% | 1,45% | 7.358.846 |
| 11/09/2014 | 57,45 | 57,67 | 57,07 | 57,35 | -1,09% | 1,05% | 8.158.890 |
| 10/09/2014 | 57,89 | 58,08 | 57,59 | 57,98 | +0,33% | 0,86% | 9.655.014 |
| 09/09/2014 | 58,05 | 58,23 | 57,70 | 57,79 | -0,80% | 0,92% | 7.800.998 |